查看购物车
  • Traditional Chinese
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1962955

病理学的未来：自动化平台、数位成像和市场动态（第三版）

The Future of Pathology: Automated Platforms, Digital Imaging, and Market Dynamics, 3rd Edition
出版日期: | 出版商: Kalorama Information | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

病理学在现代临床诊断中仍然至关重要，它提供细胞、组织和器官层面的洞察，指导疾病检测、治疗选择和患者管理。随着医疗保健越来越依赖数据和个人化，病理学的价值也不断增长。影像、染色和分子技术的进步正在加深我们对组织结构变化如何与疾病进展相关的理解。同时，不断增长的检测量和实验室数量迫使它们重新思考自身的运作方式。由 Karaorama Information 出版的 "病理学的未来：自动化平台、数位影像和市场动态" （第三版）涵盖了这些市场趋势及更多内容，并对 2025 年至 2030 年进行了估算和预测。

科技、工作流程与精准医疗塑造市场

该领域正朝着提高诊断准确性、改善可重复性和简化操作的解决方案发展。 推动这项变革的关键因素包括：

  • 对标准化、高通量病理工作流程的需求日益增长
  • 肿瘤学和精准医学应用的重要性日益凸显
  • 基于组织的生物标记分析和多重检测的广泛应用
  • 疾病定量化、资料丰富解读的趋势
  • 病理学发现与更广泛的临床系统日益融合

因此，数位病理学、自动化染色平台和人工智慧驱动的影像分析技术在各种规模的实验室中变得越来越普遍。这些创新能够更快地处理复杂样本，扩大侦测能力，并实现更一致的解读。它们还加强了组织病理学和体外诊断之间的合作，从而能够将病理数据更深入地整合到癌症治疗过程中。

研究范围

本报告对全球病理市场进行了全面分析，涵盖八大主要细分市场：

  • 传统非巴氏染色
  • 巴氏抹片检查
  • 原位杂交
  • 免疫组织化学
  • HPV检测
  • 循环肿瘤细胞
  • 流式细胞仪
  • 数位病理

本报告提供了2025年和2030年各製造商层面的市场估算和预测，包括复合年增长率（CAGR）。该报告还涵盖了北美、欧洲、亚太地区和世界其他地区的区域评估，以及2025年的竞争分析。这些估算和预测是基于广泛的一手和二手研究，包括对行业专家、公司代表、医疗保健提供者和政府官员的访谈。

预计市场将迎来显着成长

历史悠久的病理学市场依然充满活力，潜力巨大。多重检测技术、自动化和数位化分析的创新正在拓展诊断能力，提高工作流程效率，并为更深入的临床整合创造机会。 随着科技进步和全球市场的持续扩张，病理学市场预计在2030年后继续发展。

目录

第一章：摘要整理

第二章：市场概览

  • 体外诊断病理学概览
    • 组织学
    • 细胞学
    • 数位病理学
  • 病理与癌症
  • 先进分析解决方案
  • 实验室自建检测
    • 病理学临床检测的开发
  • 人工智慧与病理学

第三章：巴氏抹片检查：市场规模与成长

  • 概览
  • 市场摘要
    • 区域市场概览

第四章：原位杂交：市场规模与成长

  • 概述
  • 市场概要
    • 区域市场概览

第五章：免疫组织化学：市场规模与成长

  • 概述
  • 市场概要
    • 区域市场概览

第六章：人类乳突病毒 (HPV)：市场规模与成长

  • 概述
  • 市场概要
    • 区域市场概览

第七章：循环肿瘤细胞 (CTCS)：市场规模与成长

  • 概述
  • 市场概要
    • 区域市场概览

第八章 流式细胞仪：市场规模与成长

  • 概述
  • 市场概要
    • 区域市场概览

第九章 传统非巴氏组织学染色：市场规模与成长

  • 概述
  • 市场概要
    • 区域市场概览

第十章 数位病理：市场规模与成长

  • 概述
    • 元件概述
    • 数位病理软体
    • 数位病理扫描仪
    • 明场扫描仪
    • 萤光扫描仪
    • 全玻片扫描仪
    • A.美纳里尼诊断
    • Huron 数位病理
    • 珀金埃尔默
    • 数位病理通信与存储
  • 应用
    • 用于精准医疗的数位病理
    • 用于科学研究与教育的数位病理
    • 用于疾病诊断的数位病理
    • 医院
    • 诊断实验室
    • 疫情后恢復正常
    • 门诊诊所
    • 数位病理的其他领域（研究）
    • 生物技术和製药
    • 教育与研究
  • 市场概览
    • 区域市场概览

第11章 体外诊断病理市场概况

  • 依细分市场划分的体外诊断病理市场概览
  • 依细分市场划分的体外诊断病理市场区域
  • [亚太地区、欧洲、北美、世界其他地区]
    • 北美
    • 欧洲
    • 亚太地区
    • 世界其他地区
  • 依国家划分
  • COVID-19 对体外诊断病理学的影响（2018-2030 年）
  • 竞争分析
    • 体外诊断病理学领域四大竞争对手
    • 罗氏
    • 贝克顿‧迪金森 (BD)
    • 安捷伦
    • 丹纳赫
  • 体外诊断病理学的商业前景
简介目录
Product Code: 26-035KA

Pathology remains fundamental to modern clinical diagnostics, supplying the cellular, tissue, and organ level insights that guide disease detection, treatment selection, and patient management. As healthcare becomes more data driven and personalized, the value of pathology continues to increase. Advances in imaging, staining, and molecular techniques have improved understanding of how structural changes in tissues relate to disease progression, while rising testing volumes and workforce shortages are prompting laboratories to reassess how they operate. The Future of Pathology: Automated Platforms, Digital Imaging, and Market Dynamics, 3rd Edition by Kalorama Information covers these market trends and more with estimates and forecasts spanning 2025-2030.

A Market Shaped by Technology, Workflows, and Precision Medicine

The field is evolving toward solutions that strengthen diagnostic accuracy, improve reproducibility, and streamline operations. Several forces are driving this shift:

  • Growing need for standardized, high volume pathology workflows
  • Rising importance of oncology and precision medicine applications
  • Expanding use of tissue based biomarker analysis and multiplex assays
  • Movement toward quantitative and data rich interpretation of disease
  • Increasing integration of pathology findings into broader clinical systems

As a result, digital pathology, automated staining platforms, and artificial intelligence enabled image analytics are gaining traction across laboratories of all sizes. These innovations allow faster turnaround, expanded testing capacity, and more consistent interpretation of complex specimens. They also strengthen the link between anatomic pathology and in vitro diagnostics, enabling deeper incorporation of pathology data into cancer care pathways.

Scope of the Report

This Kalorama Information report provides a comprehensive analysis of the global pathology market across eight major segments:

  • Traditional non PAP stains
  • PAP tests
  • In situ hybridization
  • Immunohistochemistry
  • HPV testing
  • Circulating tumor cells
  • Flow cytometry
  • Digital pathology

Market estimates are provided at the manufacturer level for 2025 and 2030, including compound annual growth rates. Competitive analysis is included for 2025, along with regional assessments covering North America, Europe, Asia Pacific, and the Rest of the World. Estimates and forecasts were developed through extensive primary and secondary research including interviews with industry experts, company personnel, healthcare providers, and government officials.

A Market Positioned for Significant Growth

Despite its long history, pathology remains a dynamic market with substantial potential. Innovations in multiplexing, automation, and digital analysis are expanding diagnostic capability, improving workflow efficiency, and opening opportunities for deeper clinical integration. With continued technological progress and global expansion, the pathology market is poised for ongoing evolution through 2030 and beyond.

TABLE OF CONTENTS

CHAPTER 1: EXECUTIVE SUMMARY

  • ABOUT KALORAMA INFORMATION
  • INDUSTRY AT A GLANCE
  • SCOPE AND METHODOLOGY
  • SIZE AND GROWTH OF THE MARKET
    • Figure 1-1: Global Pathology IVD Market, 2025-2030 ($ million)
  • COMPETITIVE OUTLOOK

CHAPTER 2: MARKET OVERVIEW

  • OVERVIEW OF IVD PATHOLOGY
    • Histology
    • Cytology
    • Digital Pathology
  • PATHOLOGY AND CANCER
  • ADVANCED ANALYSIS SOLUTIONS
    • Table 2-1: Selected Advanced Pathology Techniques
  • LABORATORY DEVELOPED TESTS
    • Laboratory Developed Tests in Pathology
  • AI AND PATHOLOGY

CHAPTER 3: PAP TESTS: MARKET SIZE AND GROWTH

  • OVERVIEW
    • Table 3-1: Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2022
  • MARKET SUMMARY
    • Table 3-2: Global PAP Test Market Trend, 2020, 2025, 2030 ($ million)
    • Figure 3-1: Global PAP Test Market Trend, 2020, 2025, 2030 ($ million)
    • Regional Market Overview
      • Table 3-3: Global PAP Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, ROW]
      • Figure 3-2: Global PAP Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 4: IN SITU HYBRIDIZATION: MARKET SIZE AND GROWTH

  • OVERVIEW
    • Figure 4-1: In Situ Hybridization Indication Distribution, 2025 (%) [Oncology, Other]
    • Table 4-1: Selected in Situ Hybridization-based Tests
  • MARKET SUMMARY
    • Table 4-2: Global In Situ Hybridization Test Market Trend, 2020, 2025, 2030 ($ million)
    • Figure 4-2: Global In Situ Hybridization Test Market Trend, 2020, 2025, 2030 ($ million)
    • Regional Market Overview
      • Table 4-3: Global In Situ Hybridization IVD Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
      • Figure 4-3: Global In Situ Hybridization IVD Test Market, by Region, 2025-2030 [Asia Pacific, Europe, North America, RoW]

CHAPTER 5: IMMUNOHISTOCHEMISTRY: MARKET SIZE AND GROWTH

  • OVERVIEW
    • Figure 5-1: Immunohistochemistry Distribution, by Product Type, 2025 (%) [Equipment & Instruments, Reagents]
    • Table 5-1: Selected IHC Test Innovations
  • MARKET SUMMARY
    • Table 5-2: Global Immunohistochemistry Test Market Trend, 2020, 2025, 2030 ($ million)
    • Figure 5-2: Global Immunohistochemistry Test Market Trend, 2020, 2025, 2030 ($ million)
    • Regional Market Overview
      • Table 5-3: Global Immunohistochemistry Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
      • Figure 5-3: Global Immunohistochemistry Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 6: HUMAN PAPILLOMAVIRUS (HPV): MARKET SIZE AND GROWTH

  • OVERVIEW
    • Figure 6-1: HPV Screening Market: HPV DNA/RNA and Pap Test Distribution of Sales, 2025 (%)
    • Table 6-1: Selected HPV Test Innovations
  • MARKET SUMMARY
    • Table 6-2: Global HPV (DNA/RNA) Test Market Trend, 2020, 2025, 2030 ($ million)
    • Figure 6-2: Global HPV (DNA/RNA) Test Market Trend, 2020, 2025, 2030 ($ million)
    • Regional Market Overview
      • Table 6-3: Global HPV (DNA/RNA) Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
      • Figure 6-3: Global HPV (DNA/RNA) Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 7: CIRCULATING TUMOR CELLS (CTCS): MARKET SIZE AND GROWTH

  • OVERVIEW
    • Table 7-1: Selected CTC Test Innovations
  • MARKET SUMMARY
    • Figure 7-1: Circulating Tumor Cells (CTCs) Distribution, by Product Type, 2025 (%) [Consumables/Reagents, Equipment and Instruments]
    • Table 7-2: Global Circulating Tumor Cells (CTCs) Test Market Trend, 2020, 2025, 2030 ($ million)
    • Figure 7-2: Global Circulating Tumor Cells (CTCs) Test Market Trend, 2020, 2025, 2030 ($ million)
    • Regional Market Overview
      • Table 7-3: Global Circulating Tumor Cells (CTCs) IVD Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
      • Figure 7-3: Global Circulating Tumor Cells (CTCs) Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 8: FLOW CYTOMETRY: MARKET SIZE AND GROWTH

  • OVERVIEW
    • Table 8-1: Selected Flow Cytometry Innovations
  • MARKET OVERVIEW
    • Table 8-2: Global Flow Cytometry Test Market Trend, 2020, 2025, 2030 ($ million)
    • Figure 8-1: Global Flow Cytometry Test Market Trend, 2020, 2025, 2030 ($ million)
    • Regional Market Overview
      • Table 8-3: Global Flow Cytometry Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
      • Figure 8-2: Global Flow Cytometry Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 9: TRADITIONAL NON-PAP TISSUE STAINS: MARKET SIZE AND GROWTH

  • OVERVIEW
    • Table 9-1: Selected Traditional Tissue Stain Test Innovations
    • Table 9-2: Selected Vendors of Traditional Pathology Stains
  • MARKET SUMMARY
    • Table 9-3: Global Traditional non-Pap Tissue Stains Test Market Trend, 2020, 2025, 2030 ($ million)
    • Figure 9-1: Global Traditional non-Pap Tissue Stains Test Market Trend, 2020, 2025, 2030 ($ million)
    • Regional Market Overview
      • Table 9-4: Global Traditional non-Pap Tissue Stains Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
      • Figure 9-2: Global Traditional non-Pap Tissue Stains Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 10: DIGITAL PATHOLOGY: MARKET SIZE AND GROWTH

  • OVERVIEW
    • Component Overview
    • Digital Pathology Software
    • Digital Pathology Scanners
    • Brightfield
    • Fluorescence
    • Whole Slide Imaging
    • A. Menarini Diagnostics
    • Huron Digital Pathology
    • PerkinElmer
    • Digital Pathology Communication and Storage
    • Table 10-1: Selected Digital Pathology Innovations
  • APPLICATIONS
    • Digital Pathology for Precision Medicine
    • Digital Pathology for Research and Education
    • Digital Pathology for Disease Diagnostics
    • Hospitals
    • Diagnostic Laboratories
    • Post-Pandemic Normalization
    • Outpatient Clinics
    • Other Areas of Digital Pathology (Research Applications)
    • Biotech and Pharmaceutical Applications
    • Education and Research Applications
  • MARKET SUMMARY
    • Table 10-2: Digital Pathology Markets, by Component, 2025 ($ million) [Clinical Support Services, Hardware, Software]
    • Figure 10-1: Digital Pathology Markets, by Component, 2025 (%) [Clinical Support Services, Hardware, Software]
    • Table 10-3: Global Digital Pathology Test Market Trend, 2020, 2025, 2030 ($ million)
    • Figure 10-2: Global Digital Pathology Test Market Trend, 2020, 2025, 2030 ($ million)
    • Regional Market Overview
      • Table 10-4: Global Digital Pathology Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
      • Figure 10-3: Global Digital Pathology Test Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]

CHAPTER 11: TOTAL IVD PATHOLOGY MARKET

  • Table 11-1: Total IVD Pathology Market, Sales and Market Share by Segment, ($ million) (%) 2025-20230 [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
  • Figure 11-1: Total Global IVD Pathology Market, 2020-2030 ($ million)
  • TOTAL IVD PATHOLOGY MARKET BY SEGMENT
    • Figure 11-2: Global IVD Pathology Market, by Segment Distribution, 2025 (%) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
    • Figure 11-3: Total IVD Pathology Annual Growth, by Segment, 2020-2030 (%) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
  • IVD PATHOLOGY MARKET BY REGION
    • Table 11-2: Global Pathology Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
    • Figure 11-4: Global Pathology Market, by Region, 2025-2030 ($ million) [Asia Pacific, Europe, North America, RoW]
    • Table 11-3: Global Pathology Sales Distribution, by Region, 2025-2030 (%)
  • [Asia Pacific, Europe, North America, RoW]
    • North America
      • Table 11-4: North America Pathology Market, by Segment, 2025-2030 ($ million) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
    • Europe
      • Table 11-5: Europe Pathology Market, by Segment, 2025-2030 ($ million) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
    • Asia Pacific
      • Table 11-6: Asia Pacific Pathology Market, by Segment, 2025-2030 ($ million) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
    • Rest of World
      • Table 11-7: Rest of World Pathology Market, by Segment, 2025-2030 ($ million) [Circulating Tumor Cells (CTCs), Digital Pathology, Flow Cytometry, HPV-DNA, Immunohistochemistry, in situ Hybridization, Pap Tests, Traditional non-Pap Stains]
  • COUNTRY DISTRIBUTION
    • Figure 11-5: Total Global IVD Pathology Market Share, by Country, 2025 (%) [Australia, Canada, China, France, Germany, Italy, Japan, Spain, United Kingdom, United States, RoW]
  • IVD PATHOLOGY COVID-19 IMPACT 2018-2030
    • Historical
    • The COVID-19 Era
    • Post-COVID-19 IVD Pathology
    • Future IVD Pathology
      • Figure 11-6: COVID-19 Pandemic Impact on the IVD Pathology Market, 2018-2030 (%)
  • COMPETITIVE ANALYSIS
    • Table 11-8: Revenues of the Major Pathology Companies, 2020-2025 ($ million)
    • Figure 11-7: Global IVD Pathology Competitive Summary, 2025 (%)
    • Top Four IVD Pathology Competitors
    • Roche
      • Table 11-9: Pathology Launches by Roche
    • Beckton Dickinson (BD)
    • Agilent
    • Danaher
  • THE COMMERCIAL OUTLOOK FOR IVD PATHOLOGY